In vivo administration of anti-ROR1 specific antibody, D10 revokes the potentiating effect of ROR1 on TCL1-tg cells, suggesting that this may be a novel therapeutic target in ROR1-expressing cancers.19 The gene discussed is ROR1; the disease is cancer.